Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

P C M van de Kerkhof

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Psoriasis

Anatomy

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Cell Division

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
76
van Erp, P E J
68
de Jong, Elke
46
Gerritsen, M J P
37
Schalkwijk, Joost
30
van der Valk, P G M
22
van Vlijmen-Willems, Ivonne
20
Boezeman, Jan
19
Happle, Rudolf
16
Vissers, W H P M
15
Kuijpers, AL
15
van Hooijdonk, Candida
15
Seyger, M M B
12
de Jongh, Gys
12
van Rossum, Michelle
11
van der Vleuten, C J M

Sign-in to see all Coauthors

Publications

TOP 3
Evers A W M; Kleinpenning M M; Smits T; Boezeman J; van de Kerkhof P C M; Kraaimaat F W; Gerritsen M J P
Itch and scratching as predictors of time to clearance of psoriasis with narrow-band ultraviolet B therapy.
Verhoeven E W M; Kraaimaat F W; de Jong E M G J; Schalkwijk J; van de Kerkhof P C M; Evers A W M
Individual differences in the effect of daily stressors on psoriasis: a prospective study.
Bloem B R; Kalf J G; van de Kerkhof P C M; Zwarts M J
Debilitating consequences of drooling.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of P C M van de Kerkhof (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Evers A W M; Kleinpenning M M; Smits T; Boezeman J; van de Kerkhof P C M; Kraaimaat F W; Gerritsen M J P
Itch and scratching as predictors of time to clearance of psoriasis with narrow-band ultraviolet B therapy.
The British journal of dermatology 2009;161(3):542-6.
2009: Verhoeven E W M; Kraaimaat F W; de Jong E M G J; Schalkwijk J; van de Kerkhof P C M; Evers A W M
Individual differences in the effect of daily stressors on psoriasis: a prospective study.
The British journal of dermatology 2009;161(2):295-9.
2009: Bloem B R; Kalf J G; van de Kerkhof P C M; Zwarts M J
Debilitating consequences of drooling.
Journal of neurology 2009;256(8):1382-3.
2009: van de Kerkhof P C M; Braathen L R
Systemic therapy.
European journal of dermatology : EJD 2009;19(3):297-301.
2009: Smits T; van Laarhoven A I M; Staassen A; van de Kerkhof P C M; van Erp P E J; Gerritsen M-J P
Induction of protoporphyrin IX by aminolaevulinic acid in actinic keratosis, psoriasis and normal skin: preferential porphyrin enrichment in differentiated cells.
The British journal of dermatology 2009;160(4):849-57.
2009: van Rossum M M; Wopereis D; Hoyer T; Soerjomataram I; Schalkwijk J; van de Kerkhof P C M; Kiemeney L A L M; Hoogerbrugge N
Incidence of cancer in first-degree relatives of basal cell carcinoma patients.
Archives of dermatological research 2009;301(4):295-9.
2009: Driessen R J B; Boezeman J B; van de Kerkhof P C M; de Jong E M G J
Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
The British journal of dermatology 2009;160(3):670-5.
2009: van de Kerkhof P C M; Hoffmann V; Anstey A; Barnes L; Bolduc C; Reich K; Saari S; Segaert S; Vaillant L
A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
The British journal of dermatology 2009;160(1):170-6.
2009: Gerritsen M J P; Smits T; Kleinpenning M M; van de Kerkhof P C M; van Erp P E J
Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy.
Dermatology (Basel, Switzerland) 2009;218(3):193-202.
2008: van de Kerkhof P C M; Segaert S; Lahfa M; Luger T A; Karolyi Z; Kaszuba A; Leigheb G; Camacho F M; Forsea D; Zang C; Boussuge M P; Paolozzi L; Wajdula J
Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension.
The British journal of dermatology 2008;159(5):1177-85.
2008: van Lingen R G; Poll M K P; Seyger M M B; de Jong E M G J; van de Kerkhof P C M; van Erp P E J
Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers.
Archives of dermatological research 2008;300(10):561-7.
2008: Driessen R J B; de Jong E M G J; de Rie M A; Salemink G W; van de Kerkhof P C M
Analysis of 3-year national reimbursement application data on etanercept and efalizumab for psoriasis.
The British journal of dermatology 2008;159(3):760-1.
2008: Driessen R J B; van de Kerkhof P C M; de Jong E M G J
Etanercept combined with methotrexate for high-need psoriasis.
The British journal of dermatology 2008;159(2):460-3.
2008: van Lingen R G; Körver J E M; van de Kerkhof P C M; Berends M A M; van Rens D W A; Langewouters A M; Boezeman J B M; Seyger M M B; de Jong E M G J
Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: effect of immune-targeted antipsoriatic therapies.
The British journal of dermatology 2008;159(1):91-6.
2008: Kroft E B M; van de Kerkhof P C M; Gerritsen M J P; de Jong E M G J
Period of remission after treatment with UVA-1 in sclerodermic skin diseases.
Journal of the European Academy of Dermatology and Venereology : JEADV 2008;22(7):839-44.
2008: van de Kerkhof P C M; Barker J; Griffiths C E M; Kragballe K; Mason J; Menter A; Papp K
Psoriasis: consensus on topical therapies.
Journal of the European Academy of Dermatology and Venereology : JEADV 2008;22(7):859-70.
2008: van Lingen R G; van de Kerkhof P C M; Seyger M M B; de Jong E M G J; van Rens D W A; Poll M K P; Zeeuwen P L J M; van Erp P E J
CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.
The British journal of dermatology 2008;158(6):1264-72.
2008: Driessen R J B; Berends M A M; Boezeman J B; van de Kerkhof P C M; de Jong E M G J
Psoriasis treatment with etanercept and efalizumab: clinical strategies influencing treatment outcome.
The British journal of dermatology 2008;158(5):1098-106.
2008: Vissers W H P M; van Vlijmen I; van Erp P E J; de Jong E M G J; van de Kerkhof P C M
Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
The British journal of dermatology 2008;158(4):705-12.
2008: Langewouters A M G; van Erp P E J; de Jong E M G J; van de Kerkhof P C M
Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis.
Archives of dermatological research 2008;300(3):107-13.
2008: de Korte J; van der Valk P G M; Sprangers M A G; Damstra R J; Kunkeler A C M; Lijnen R L P; Oranje A P; de Rie M A; de Waard-van der Spek F B; Hol C W; van de Kerkhof P C M
A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
The British journal of dermatology 2008;158(2):375-81.
2008: Hollox Edward J; Huffmeier Ulrike; Zeeuwen Patrick L J M; Palla Raquel; Lascorz Jesús; Rodijk-Olthuis Diana; van de Kerkhof Peter C M; Traupe Heiko; de Jongh Gys; den Heijer Martin; Reis André; Armour John A L; Schalkwijk Joost
Psoriasis is associated with increased beta-defensin genomic copy number.
Nature genetics 2008;40(1):23-5.
2008: Evers A W M; Duller P; van de Kerkhof P C M; van der Valk P G M; de Jong E M G J; Gerritsen M J P; Otero E; Verhoeven E W M; Verhaak C M; Kraaimaat F W
The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument.
The British journal of dermatology 2008;158(1):101-8.
2008: Vissers W H P M; van Duijnhoven M; van Erp P E J; de Jong E M G J; van de Kerkhof P C M
The effect of alefacept on T-cell subsets and cells expressing NK receptors in lesional psoriatic skin: the effects of monotherapy and combination treatment with calcipotriol.
The Journal of dermatological treatment 2008;19(6):344-50.
2007: Berends Maartje A M; van Oijen Martijn G H; Snoek Josje; van de Kerkhof Peter C M; Drenth Joost P H; Han van Krieken J; de Jong Elke M G J
Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens.
Archives of dermatology 2007;143(12):1515-9.
2007: Ulrich C; Bichel J; Euvrard S; Guidi B; Proby C M; van de Kerkhof P C M; Amerio P; Rønnevig J; Slade H B; Stockfleth E
Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients.
The British journal of dermatology 2007;157 Suppl 2():25-31.
2007: Smits Tim; Kleinpenning Marloes M; Blokx Willeke A M; van de Kerkhof Peter C M; van Erp Piet E J; Gerritsen Marie-Jeanne P
Fluorescence diagnosis in keratinocytic intraepidermal neoplasias.
Journal of the American Academy of Dermatology 2007;57(5):824-31.
2007: Heinen Maud M; Persoon Anke; van de Kerkhof Peter; Otero Marisol; van Achterberg Theo
Ulcer-related problems and health care needs in patients with venous leg ulceration: a descriptive, cross-sectional study.
International journal of nursing studies 2007;44(8):1296-303.
2007: van Laarhoven A I M; Kraaimaat F W; Wilder-Smith O H; van de Kerkhof P C M; Cats H; van Riel P L C M; Evers A W M
Generalized and symptom-specific sensitization of chronic itch and pain.
Journal of the European Academy of Dermatology and Venereology : JEADV 2007;21(9):1187-92.
2007: Heinen M M; Evers A W M; Van Uden C J T; Van der Vleuten C J M; van de Kerkhof P C M; Van Achterberg T
Sedentary patients with venous or mixed leg ulcers: determinants of physical activity.
Journal of advanced nursing 2007;60(1):50-7.
2007: Verfaille C J; Thissen C A C B; Bovenschen H J; Mertens J; Steijlen P M; van de Kerkhof P C M
Oral R115866 in the treatment of moderate to severe plaque-type psoriasis.
Journal of the European Academy of Dermatology and Venereology : JEADV 2007;21(8):1038-46.
2007: Roelofzen Judith H J; Aben Katja K H; Khawar Ali J M; Van de Kerkhof Peter C M; Kiemeney Lambertus A L M; Van Der Valk Pieter G M
Treatment policy for psoriasis and eczema: a survey among dermatologists in the Netherlands and Belgian Flanders.
European journal of dermatology : EJD 2007;17(5):416-21.
2007: Sibelt L A G; Lokhorst H M; van de Kerkhof P C M; van Dooren-Greebe R J
A 'muscle' man without exercise: muscle pseudohypertrophy in myeloma-associated generalized amyloidosis.
Journal of the European Academy of Dermatology and Venereology : JEADV 2007;21(7):986-8.
2007: van de Kerkhof P C M
The evolution of the psoriatic lesion.
The British journal of dermatology 2007;157(1):4-15.
2007: Verhoeven E W M; Kraaimaat F W; van de Kerkhof P C M; van Weel C; Duller P; van der Valk P G M; van den Hoogen H J M; Bor J H J; Schers H J; Evers A W M
Prevalence of physical symptoms of itch, pain and fatigue in patients with skin diseases in general practice.
The British journal of dermatology 2007;156(6):1346-9.
2007: Berends Maartje A M; Snoek Josje; de Jong Elke M G J; Van Krieken J Han; de Knegt Robert J; van Oijen Martijn G H; van de Kerkhof Peter C M; Drenth Joost P H
Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(5):639-45.
2007: Verhoeven E W M; Kraaimaat F W; van de Kerkhof P C M; van Weel C; Duller P; van der Valk P G M; van den Hoogen H J M; Bor J H J; Schers H J; Evers A W M
Psychosocial well-being of patients with skin diseases in general practice.
Journal of the European Academy of Dermatology and Venereology : JEADV 2007;21(5):662-8.
2007: van de Kerkhof P C M; Mrowietz U; Segaert S; Kragballe K
Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity?
The British journal of dermatology 2007;156(4):771-2.
2007: Bovenschen H J; Otero M E; Langewouters A M G; van Vlijmen-Willems I M J J; van Rens D W A; Seyger M M B; van de Kerkhof P C M
Oral retinoic acid metabolism blocking agent Rambazole for plaque psoriasis: an immunohistochemical study.
The British journal of dermatology 2007;156(2):263-70.
2007: Smits Tim; Olthuis Diana; Blokx Willeke A M; Kleinpenning Marloes M; van de Kerkhof Peter C M; van Erp Piet E J; Gerritsen Marie-Jeanne P
Aneuploidy and proliferation in keratinocytic intraepidermal neoplasias.
Experimental dermatology 2007;16(2):81-6.
2007: Bovenschen H J; Gerritsen W J; van Rens D W A; Seyger M M B; de Jong E M G J; van de Kerkhof P C M
Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
Archives of dermatological research 2007;298(9):457-63.
2007: Körver J E M; Vissers W H P M; van Rens D W A; Pasch M C; van Erp P E J; Boezeman J B M; van De Kerkhof P C M
A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation.
The British journal of dermatology 2007;156(1):130-7.
2007: van de Kerkhof Peter C M
The skin is not lying.
The Journal of dermatological treatment 2007;18(5):260.
2007: Roelofzen Judith H J; Aben Katja K H; van der Valk Pieter G M; van Houtum Jeanette L M; van de Kerkhof Peter C M; Kiemeney Lambertus A L M
Coal tar in dermatology.
The Journal of dermatological treatment 2007;18(6):329-34.
2007: Langewouters Annechien M G; Bovenschen H Jorn; De jong Elke M G J; Van Erp Piet E J; Van De Kerkhof Peter C M
The effect of topical corticosteroids in combination with alefacept on circulating T-cell subsets in psoriasis.
The Journal of dermatological treatment 2007;18(5):279-85.
2007: Berends M A M; de Jong E M G J; van de Kerkhof P C M; Gerritsen M J P
Dermatologists' adherence to the guideline of the Dutch Society of Dermatology and Venereology with respect to the treatment with methotrexate for severe chronic plaque psoriasis: results from a Dutch survey.
Dermatology (Basel, Switzerland) 2007;215(1):45-52.
2007: Berends Maartje A M; Driessen Rieke J B; Langewouters Annechien M G; Boezeman Jan B; Van De Kerkhof Peter C M; De Jong Elke M G J
Etanercept and efalizumab treatment for high-need psoriasis. Effects and side effects in a prospective cohort study in outpatient clinical practice.
The Journal of dermatological treatment 2007;18(2):76-83.
2007: Bovenschen H Jorn; Erceg Angelina; Van Vlijmen-Willems Ivonne; Van De Kerkhof Peter C M; Seyger Marieke M B
Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
The Journal of dermatological treatment 2007;18(1):32-9.
2006: Körver J E M; Langewouters A M G; Van De Kerkhof P C M; Pasch M C
Therapeutic effects of a 12-week course of alefacept on nail psoriasis.
Journal of the European Academy of Dermatology and Venereology : JEADV 2006;20(10):1252-5.
2006: van de Kerkhof P C M; van der Valk P G M; Swinkels O Q J; Kucharekova M; de Rie M A; de Vries H J C; Damstra R; Oranje A P; de Waard-van der Spek F B; van Neer P; Lijnen R L P; Kunkeler A C M; van Hees C; Haertlein N G J; Hol C W
A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
The British journal of dermatology 2006;155(4):800-7.
2006: Dubertret L; Mrowietz U; Ranki A; van de Kerkhof P C M; Chimenti S; Lotti T; Schäfer G;
European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey.
The British journal of dermatology 2006;155(4):729-36.
2006: Körver J E M; van Duijnhoven M W F M; Pasch M C; van Erp P E J; van de Kerkhof P C M
Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis.
The British journal of dermatology 2006;155(4):688-94.
2006: van de Kerkhof Peter C M
Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology.
Dermatologic therapy 2006;19(5):252-63.
2006: Berends M A M; Snoek J; de Jong E M G J; van de Kerkhof P C M; van Oijen M G H; van Krieken J H; Drenth J P H
Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.
Alimentary pharmacology & therapeutics 2006;24(5):805-11.
2006: Kleinpenning M M; Smits T; Ewalds E; van Erp P E J; van de Kerkhof P C M; Gerritsen M J P
Heterogeneity of fluorescence in psoriasis after application of 5-aminolaevulinic acid: an immunohistochemical study.
The British journal of dermatology 2006;155(3):539-45.
2006: van de Kerkhof P C M
[Initiatives to increase the efficiency of dermatological patient care]
Nederlands tijdschrift voor geneeskunde 2006;150(34):1873-6.
2006: Smits T; Kleinpenning M M; van Erp P E J; van de Kerkhof P C M; Gerritsen M-J P
A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasis.
The British journal of dermatology 2006;155(2):429-36.
2006: van de Kerkhof P C M
Consistent control of psoriasis by continuous long-term therapy: the promise of biological treatments.
Journal of the European Academy of Dermatology and Venereology : JEADV 2006;20(6):639-50.
2006: Erceg A; Bovenschen H J; van de Kerkhof P C M; Seyger M M B
Efficacy of the pulsed dye laser in the treatment of localized recalcitrant plaque psoriasis: a comparative study.
The British journal of dermatology 2006;155(1):110-4.
2006: Bovenschen H J; Tjioe M; Vermaat H; de Hoop D; Witteman B M J; Janssens R W A; Stoof T J; van de Kerkhof P C M
Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals.
The British journal of dermatology 2006;154(5):880-4.
2006: Heinen Maud M; Bartholomew L Kay; Wensing Michel; van de Kerkhof Peter; van Achterberg Theo
Supporting adherence and healthy lifestyles in leg ulcer patients: systematic development of the Lively Legs program for dermatology outpatient clinics.
Patient education and counseling 2006;61(2):279-91.
2006: Körver John E M; van de Kerkhof Peter C M; Pasch Marcel C
Alefacept treatment of psoriatic nail disease: how severe should nail psoriasis be?
Journal of the American Academy of Dermatology 2006;54(4):742-3.
2006: van de Kerkhof Peter C M; Kragballe Knud; Austad Joar; Berth-Jones John; Cambazard Frédéric; de la Brassinne Michel; Ljungberg Anders; Murphy Gillian; Papp Kim; Wozel Gottfried
Psoriasis: severity assessment in clinical practice. Conclusions from workshop discussions and a prospective multicentre survey of psoriasis severity.
European journal of dermatology : EJD 2006;16(2):167-71.
2006: Kragballe K; van de Kerkhof P C M
Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis.
Journal of the European Academy of Dermatology and Venereology : JEADV 2006;20(1):39-44.
2006: van Duijnhoven M W F M; Körver J E M; Vissers W H P M; van Vlijmen-Willems I M J J; Pasch M C; van Erp P E J; Van de Kerkhof P C M
Effect of calcipotriol on epidermal cell populations in alefacept-treated psoriatic lesions.
Journal of the European Academy of Dermatology and Venereology : JEADV 2006;20(1):27-33.
2006: Bovenschen H Jorn; Kop Else N; Van De Kerkhof Peter C M; Seyger Marieke M B
Etanercept-induced lichenoid reaction pattern in psoriasis.
The Journal of dermatological treatment 2006;17(6):381-3.
2006: Langewouters Annechien M G; Van Erp Piet E J; De Jong Elke M G J; Van De Kerkhof Peter C M
The added therapeutic efficacy and safety of alefacept in combination with other (systemic) anti-psoriatics in refractory psoriasis.
The Journal of dermatological treatment 2006;17(6):362-9.
2006: van de Kerkhof Peter C M
How to position antipsoriatic treatments?
The Journal of dermatological treatment 2006;17(6):325-6.
2006: Verhoeven Lisette; Kraaimaat Floris; Duller Piet; van de Kerkhof Peter; Evers Andrea
Cognitive, behavioral, and physiological reactivity to chronic itching: analogies to chronic pain.
International journal of behavioral medicine 2006;13(3):237-43.
2006: van de Kerkhof Peter C M; Kleinpenning Marloes M; de Jong Elke M G J; Gerritsen Marie-Jeanne P; van Dooren-Greebe Rens J; Alkemade Hans A C
Current and future treatment options for acne.
The Journal of dermatological treatment 2006;17(4):198-204.
2006: Bovenschen H J; van Vlijmen-Willems I M J J; van de Kerkhof P C M; van Erp P E J
Identification of lesional CD4+ CD25+ Foxp3+ regulatory T cells in Psoriasis.
Dermatology (Basel, Switzerland) 2006;213(2):111-7.
2006: Bovenschen H Jorn; Gerritsen Wil-Janne; de Jong Elke M G J; van de Kerkhof Peter C M
Addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
Acta dermato-venereologica 2006;86(3):281-2.
2006: Ortonne Jean-Paul; van de Kerkhof Peter C M; Prinz Jörg C; Bieber Thomas; Lahfa Morad; Rubins Andris; Wozel Gottfried; Lorette Gérard;
0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study.
Acta dermato-venereologica 2006;86(1):29-33.
2005: van de Kerkhof P C M
Once daily vs. twice daily applications of topical treatments in psoriasis.
The British journal of dermatology 2005;153(6):1245.
2005: Bovenschen H J; Van De Kerkhof P C M; Gerritsen W J; Seyger M M B
The role of lesional T cells in recalcitrant psoriasis during infliximab therapy.
European journal of dermatology : EJD 2005;15(6):454-8.
2005: van de Kerkhof P C M; van Rossum M M; Hengstman G J D; Bloem B R
Follicular cysts and hyperkeratoses as first manifestation, and involvement of the central nervous system as late manifestation of mycosis fungoides.
Journal of the European Academy of Dermatology and Venereology : JEADV 2005;19(6):777-9.
2005: van de Kerkhof Peter C M; Pasch Marcel C; Scher Richard K; Kerscher Martina; Gieler Uwe; Haneke Eckard; Fleckman Philip
Brittle nail syndrome: a pathogenesis-based approach with a proposed grading system.
Journal of the American Academy of Dermatology 2005;53(4):644-51.
2005: Smits Tim; Robles Cesar A; van Erp Piet E J; van de Kerkhof Peter C M; Gerritsen Marie-Jeanne P
Correlation between macroscopic fluorescence and protoporphyrin IX content in psoriasis and actinic keratosis following application of aminolevulinic acid.
The Journal of investigative dermatology 2005;125(4):833-9.
2005: van Duijnhoven M W F; de Jong E M G J; Gerritsen W J; Pasch M C; van de Kerkhof P C M
Alefacept modifies long-term disease severity and improves the response to other treatments.
European journal of dermatology : EJD 2005;15(5):366-73.
2005: Bovenschen H J; Seyger M M B; Van de Kerkhof P C M
Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
The British journal of dermatology 2005;153(1):72-8.
2005: van de Kerkhof P C M; Kragballe K
Recommendations for the topical treatment of psoriasis.
Journal of the European Academy of Dermatology and Venereology : JEADV 2005;19(4):495-9.
2005: Papp K A; Tyring S; Lahfa M; Prinz J; Griffiths C E M; Nakanishi A M; Zitnik R; van de Kerkhof P C M; Melvin Linda;
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.
The British journal of dermatology 2005;152(6):1304-12.
2005: Evers A W M; Lu Y; Duller P; van der Valk P G M; Kraaimaat F W; van de Kerkhof P C M
Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis.
The British journal of dermatology 2005;152(6):1275-81.
2005: Kroft E B M; Erceg A; Maimets K; Vissers W; van der Valk P G M; van de Kerkhof P C M
Tacrolimus ointment for the treatment of severe facial plaque psoriasis.
Journal of the European Academy of Dermatology and Venereology : JEADV 2005;19(2):249-51.
2005: Katsambas A; Abeck D; Haneke E; van de Kerkhof P; Burzykowski T; Molenberghs G; Marynissen G
The effects of foot disease on quality of life: results of the Achilles Project.
Journal of the European Academy of Dermatology and Venereology : JEADV 2005;19(2):191-5.
2005: Kucharekova M; Lieffers L; van de Kerkhof P C M; van der Valk P G M
Dithranol irritation in psoriasis treatment: a study of 68 inpatients.
Journal of the European Academy of Dermatology and Venereology : JEADV 2005;19(2):176-9.
2005: van de Kerkhof P C M
The topical treatment of psoriasis.
Clinical and experimental dermatology 2005;30(2):205-8.
2005: van Duijnhoven Mirella W F M; van de Kerkhof Peter C M; Pasch Marcel C; Muys Leon; van Erp Piet E J
The combination of the Zenon labeling technique and microscopic image analysis to study cell populations in normal and psoriatic epidermis.
Journal of cutaneous pathology 2005;32(3):212-9.
2005: Franssen Manon E J; Zeeuwen Patrick L J M; Vierwinden Gerty; van de Kerkhof Peter C M; Schalkwijk Joost; van Erp Piet E J
Phenotypical and functional differences in germinative subpopulations derived from normal and psoriatic epidermis.
The Journal of investigative dermatology 2005;124(2):373-83.
2005: Vissers W H P M; Roelofzen J; De Jong E M G J; Van Erp P E J; Van de Kerkhof P C M
Flexural versus plaque lesions in psoriasis: an immunohistochemical differentiation.
European journal of dermatology : EJD 2005;15(1):13-7.
2005: Tjioe M; Otero M E; van de Kerkhof P C M; Gerritsen M J P
Quality of life in vitiligo patients after treatment with long-term narrowband ultraviolet B phototherapy.
Journal of the European Academy of Dermatology and Venereology : JEADV 2005;19(1):56-60.
2005: Van de Kerkhof P C M
Perceptions on the treatment of psoriasis.
The Journal of dermatological treatment 2005;16(5-6):255-6.
2005: van Duijnhoven Mirella W F M; Hagenberg Ronald; Pasch Marcel C; van Erp Piet E J; van de Kerkhof Peter C M
Novel quantitative immunofluorescent technique reveals improvements in epidermal cell populations after mild treatment of psoriasis.
Acta dermato-venereologica 2005;85(4):311-7.
2005: Prins Mandy; Krabbe Paul F M; Swinkels Quintus O J; de Boo Theo; van de Kerkhof Peter C M; van der Valk Pieter G M
The effect of treatment on quality of life in psoriasis patients.
Acta dermato-venereologica 2005;85(4):304-10.
2005: van de Kerkhof P C M; Wasel N; Kragballe K; Cambazard F; Murray S
A two-compound product containing calcipotriol and betamethasone dipropionate provides rapid, effective treatment of psoriasis vulgaris regardless of baseline disease severity.
Dermatology (Basel, Switzerland) 2005;210(4):294-9.
2005: Flendrie Marcel; Vissers Wynand H P M; Creemers Marjonne C W; de Jong Elke M G J; van de Kerkhof Peter C M; van Riel Piet L C M
Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study.
Arthritis research & therapy 2005;7(3):R666-76.
2005: Bovenschen H Jorn; Vissers Wynand H P M; Seyger Marieke M B; van de Kerkhof Peter C M
Selective persistence of dermal CD8+ T cells in lesional plaque psoriasis after clobetasol-17 propionate treatment.
Acta dermato-venereologica 2005;85(2):113-7.
2004: van de Kerkhof P C M
The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
The British journal of dermatology 2004;151(3):663-8.
2004: Mommers J M Roland; Seyger Marieke M B; van der Vleuten Carine J M; van de Kerkhof Peter C M
Interdigital psoriasis (psoriasis alba): renewed attention for a neglected disorder.
Journal of the American Academy of Dermatology 2004;51(2):317-8.
2004: Smit Jürgen V; de Jong Elke M G J; van Hooijdonk Candida A E M; Otero Marisol E; Boezeman Jan B M; van de Kerkhof Peter C M
Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin.
Journal of the American Academy of Dermatology 2004;51(2):257-64.
2004: Smit Jürgen V; Franssen Manon E J; de Jong Elke M G J; Lambert Julien; Roseeuw Diane I; De Weert Jozef; Yocum Richard C; Stevens Victor J; van De Kerkhof P C M
A phase II multicenter clinical trial of systemic bexarotene in psoriasis.
Journal of the American Academy of Dermatology 2004;51(2):249-56.
2004: Blok S; Vissers W H P M; van Duijnhoven M; van de Kerkhof P C M
Aggravation of psoriasis by infections: a constitutional trait or a variable expression?
European journal of dermatology : EJD 2004;14(4):259-61.
2004: Vissers W H P M; Muys L; Erp P E J Van; de Jong E M G J; van de Kerkhof P C M
Immunohistochemical differentiation between inflammatory linear verrucous epidermal nevus (ILVEN) and psoriasis.
European journal of dermatology : EJD 2004;14(4):216-20.
2004: van de Kerkhof Peter C M; Vissers Wijnand H P M
Established treatments of psoriasis.
Current drug targets. Inflammation and allergy 2004;3(2):145-56.
2004: Sminkels O Q J; Prins M; Veeniiuis R T; De Boo T; Gerritsen M J P; Van Der Wilt G J; Van De Kerkhof P C M; Van Der Valk P G M
Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis.
European journal of dermatology : EJD 2004;14(3):159-65.
2004: Vissers W H P M; Arndtz C H M; Muys L; Van Erp P E J; de Jong E M G; van de Kerkhof P C M
Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late.
The British journal of dermatology 2004;150(5):852-9.
2004: Steijlen Peter M; van Steensel Maurice A M; Jansen Bastiaan J H; Blokx Willeke; van de Kerkhof Peter C M; Happle Rudolf; van Geel Michel
Cryptic splicing at a non-consensus splice-donor in a patient with a novel mutation in the plakophilin-1 gene.
The Journal of investigative dermatology 2004;122(5):1321-4.
2004: Heinen Maud M; van Achterberg Theo; op Reimer Wilma Scholte; van de Kerkhof Peter C M; de Laat Erik
Venous leg ulcer patients: a review of the literature on lifestyle and pain-related interventions.
Journal of clinical nursing 2004;13(3):355-66.
2004: Persoon Anke; Heinen Maud M; van der Vleuten Carien J M; de Rooij Michette J; van de Kerkhof Peter C M; van Achterberg Theo
Leg ulcers: a review of their impact on daily life.
Journal of clinical nursing 2004;13(3):341-54.
2004: Vissers W H P M; Berends M; Muys L; van Erp P E J; de Jong E M G J; van de Kerkhof P C M
The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
Experimental dermatology 2004;13(2):106-12.
2004: Smit Jürgen V; de Sévaux Ruud G L; Blokx Willeke A M; van de Kerkhof Peter C M; Hoitsma Andries J; de Jong Elke M G J
Acitretin treatment in (pre)malignant skin disorders of renal transplant recipients: Histologic and immunohistochemical effects.
Journal of the American Academy of Dermatology 2004;50(2):189-96.
2004: Franssen M E J; Boezeman J B M; Van De Kerkhof P C M; Van Erp P E J
Monitoring hyperproliferative disorders in human skin: flow cytometry of changing cytokeratin expression.
Cytometry. Part B, Clinical cytometry 2004;57(1):32-9.
2004: van Rossum Michelle M; Franssen Mainon E J; Cloin Wendy A H; van de Bosch Gerard J M; Boezeman Jan B M; Schalkwijk Joost; van de Kerkhof Peter C M; van Erp Piet E J
Functional characterization of beta1-integrin-positive epidermal cell populations.
Acta dermato-venereologica 2004;84(4):265-70.
2004: Franssen Mannon E J; de Jongh Gys J; van Erp Piet E J; van de Kerkhof Peter C M
A left/right comparison of twice-daily calcipotriol ointment and calcitriol ointment in patients with psoriasis: the effect on keratinocyte subpopulations.
Acta dermato-venereologica 2004;84(3):195-200.
2003: Tjioe M; Smits T; van de Kerkhof P C M; Gerritsen M J P
The differential effect of broad band vs narrow band UVB with respect to photodamage and cutaneous inflammation.
Experimental dermatology 2003;12(6):729-33.
2003: Burzykowski T; Molenberghs G; Abeck D; Haneke E; Hay R; Katsambas A; Roseeuw D; van de Kerkhof P; van Aelst R; Marynissen G
High prevalence of foot diseases in Europe: results of the Achilles Project.
Mycoses 2003;46(11-12):496-505.
2003: van de Kerkhof Peter C M
[Treatment options in monogenic disorders of keratinization]
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2003;1(10):763-4.
2003: Tjioe Milan; Smits Tim; Blokx Willeke A M; van de Kerkhof Peter C M; Gerritsen Marie-Jeanne P
High-dose long wave visible light induces perinuclear vacuolization in vivo but does not result in early photoageing and apoptosis.
Experimental dermatology 2003;12(5):610-4.
2003: Franssen M E J; Smit J V; Van Erp P E J; Van De Kerkhof P C M
A multiparameter flow cytometric analysis of the effect of bexarotene on the epidermis of the psoriatic lesion.
The British journal of dermatology 2003;149(3):506-12.
2003: Blokx Willeke A M; de Jong Elke M G J; de Wilde Peter C M; Bulten Johan; Link Monique M G M; Ruiter Dirk J; van de Kerkhof Peter C M
P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2003;16(9):869-78.
2003: de Sévaux R G L; Smit J V; de Jong E M G J; van de Kerkhof P C M; Hoitsma A J
Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin.
Journal of the American Academy of Dermatology 2003;49(3):407-12.
2003: Tjioe M; Gerritsen M J P; Den Broeder A A; Van Hooijdonk C A E M; Kroot E J A; Van Riel P L C M; Barrera P; Van De Kerkhof P C M
Adalimumab, a fully human anti-TNF-alpha monoclonal antibody, treatment does not influence experimental UV response in the skin of rheumatoid arthritis patients.
Experimental dermatology 2003;12(4):460-5.
2003: Smit J V; De Jong E M G J; Van De Kerkhof P C M
Effects of oral bexarotene (targretin) on the minimal erythema dose for broadspectrum UVB light.
Skin pharmacology and applied skin physiology 2003;16(4):237-41.
2003: Kucharekova M; Van De Kerkhof P C M; Van Der Valk P G M
A randomized comparison of an emollient containing skin-related lipids with a petrolatum-based emollient as adjunct in the treatment of chronic hand dermatitis.
Contact dermatitis 2003;48(6):293-9.
2003: Kucharekova Martin; Vissers Wynand H P M; Schalkwijk Joost J; van de Kerkhof Peter C M; van der Valk Peter G M
Lack of upregulation of epidermal fatty acid binding protein in dithranol induced irritation.
European journal of dermatology : EJD 2003;13(3):254-7.
2003: Vissers Wynand; Van Steensel Maurice; Steijlen Peter; Renier Willy; Van De Kerkhof Peter; Van Der Vleuten Carine
Klippel-Trenaunay syndrome and Sturge-Weber syndrome: variations on a theme?
European journal of dermatology : EJD 2003;13(3):238-41.
2003: Blokx Willeke A M; Smit Jurgen V; de Wilde Peter C M; van de Kerkhof Peter C M; Ruiter Dirk J; de Jong Elke M G J
Immunohistochemical effects of temporary cessation of long-term acitretin treatment in keratinocytic intraepidermal neoplasia of renal transplant recipients.
Archives of dermatology 2003;139(5):671-3.
2003: Kucharekova M; Hornix M; Ashikaga T; T'kint S; de Jongh G J; Schalkwijk J; van de Kerkhof P C M; van der Valk P G M
The effect of the PDE-4 inhibitor (cipamfylline) in two human models of irritant contact dermatitis.
Archives of dermatological research 2003;295(1):29-32.
2003: van de Kerkhof P C M; Vissers W H P M
The topical treatment of psoriasis.
Skin pharmacology and applied skin physiology 2003;16(2):69-83.
2003: de Jong E M G J; Mørk N J; Seijger M M B; De La Brassine M; Lauharanta J; Jansen C T; Guilhou J J; Guillot B; Ostrojic A; Souteyrand P; Vaillant L; Barnes L; Rogers S; Klaber M R; Van De Kerkhof P C M
The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial.
The British journal of dermatology 2003;148(2):318-25.
2003: Swinkels O Q J; Kucharekova M; Prins M; Gerritsen M J P; van der Valk P G M; van de Kerkhof P C M
The effects of topical corticosteroids and a coal tar preparation on dithranol-induced irritation in patients with psoriasis.
Skin pharmacology and applied skin physiology 2003;16(1):12-7.
2003: Papp Kim A; Guenther Lyn; Boyden Bernard; Larsen Frederik Grønhøj; Harvima Rauno J; Guilhou Jean Jacques; Kaufmann Roland; Rogers Sarah; van de Kerkhof Peter C M; Hanssen Leif I; Tegner Eva; Burg Günter; Talbot David; Chu Anthony
Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis.
Journal of the American Academy of Dermatology 2003;48(1):48-54.
2002: Swinkels O Q J; Prins M; Gerritsen M J P; van Vlijmen-Willems I M J J; van der Valk P G M; van de Kerkhof P C M
An immunohistochemical assessment of the response of the psoriatic lesion to single and repeated applications of high-dose dithranol cream.
Skin pharmacology and applied skin physiology 2002;15(6):393-400.
2002: Swinkels O Q J; Prins M; van Vlijmen-Willems I M J J; Gerritsen M J P; van der Valk P G M; van de Kerkhof P C M
The response of uninvolved skin of patients with psoriasis to single and repeated applications of dithranol cream: an immunohistochemical assessment.
Skin pharmacology and applied skin physiology 2002;15(6):385-92.
2002: van de Kerkhof Peter
Vitamin D and systemic therapy.
Cutis; cutaneous medicine for the practitioner 2002;70(5 Suppl):16-20.
2002: Hartman M; Prins M; Swinkels O Q J; Severens J L; De Boo Th; Van Der Wilt G J; Van De Kerkhof P C M; Van Der Valk P G M
Cost-effectiveness analysis of a psoriasis care instruction programme with dithranol compared with UVB phototherapy and inpatient dithranol treatment.
The British journal of dermatology 2002;147(3):538-44.
2002: van Rossum M M; Schalkwijk J; van de Kerkhof P C M; van Erp P E J
Immunofluorescent surface labelling, flow sorting and culturing of putative epidermal stem cells derived from small skin punch biopsies.
Journal of immunological methods 2002;267(2):109-17.
2002: Guenther L; Van de Kerkhof P C M; Snellman E; Kragballe K; Chu A C; Tegner E; Garcia-Diez A; Springborg J
Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial.
The British journal of dermatology 2002;147(2):316-23.
2002: Swinkels O Q J; Prins M; Birker L W J; Gerritsen M J P; van der Valk P G M; van de Kerkhof P C M
The response of normal human skin to single and repeated applications of dithranol cream: an immunohistochemical assessment.
Skin pharmacology and applied skin physiology 2002;15(4):262-9.
2002: Toonstra Johan; Lier Jan G; Steijlen Peter M; van de Kerkhof Peter C M
Graft-versus-host disease-like eruption preceding a nodal CD30+ lymphoma.
European journal of dermatology : EJD 2002;12(4):364-6.
2002: Kucharekova M; Schalkwijk J; Van De Kerkhof P C M; Van De Valk P G M
Effect of a lipid-rich emollient containing ceramide 3 in experimentally induced skin barrier dysfunction.
Contact dermatitis 2002;46(6):331-8.
2002: Swinkels O Q J; Prins M; Kucharekova M; de Boo T; Gerritsen M J P; van der Valk P G M; van de Kerkhof P C M
Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid.
The British journal of dermatology 2002;146(4):621-6.
2002: van de Kerkhof P C M; Berth-Jones J; Griffiths C E M; Harrison P V; Hönigsmann H; Marks R; Roelandts R; Schöpf E; Trompke C
Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis.
The British journal of dermatology 2002;146(3):414-22.
2002: Glade C P; van der Vleuten C J M; van Erp P E J; van de Kerkhof P C M
Flow cytometric assessment of clearance and relapse characteristics in psoriasis vulgaris after treatment with weekly clobetasol lotion under hydrocolloid occlusion versus twice-daily clobetasol ointment.
Skin pharmacology and applied skin physiology 2002;15(2):92-9.
2002: Blokx Willeke A M; Smit Jurgen V; de Jong Elke M G J; Link Monique M G M; van de Kerkhof Peter C M; Ruiter Dirk J
Retinoids strongly and selectively correlate with keratin 13 and not keratin 19 expression in cutaneous warts of renal transplant recipients.
Archives of dermatology 2002;138(1):61-5.
2002: Tjioe M; Gerritsen M J P; Juhlin L; van de Kerkhof P C M
Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12.
Acta dermato-venereologica 2002;82(5):369-72.
2002: Tjioe Milan; Gerritsen Marie-Jeanne P; van de Kerkhof Peter C M
Remarkable success of Chinese herbs in combination with a short course of low-dose narrow-band UVB phototherapy in severe recalcitrant plaque psoriasis.
Acta dermato-venereologica 2002;82(4):299-300.
2002: Van de Kerkhof P C M; Green C; Hamberg K J; Hutchinson P E; Jensen J K; Kidson P; Kragballe K; Larsen F G; Munro C S; Tillman D M
Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis.
Dermatology (Basel, Switzerland) 2002;204(3):214-21.
2001: Swinkels O Q; Prins M; Tosserams E F; Gerritsen M J; Van Der Valk P G; Van De Kerkhof P C
The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
The British journal of dermatology 2001;145(1):63-9.
2001: van de Kerkhof P C; Franssen M; de La Brassine M; Kuipers M
Calcipotriol cream in the morning and ointment in the evening: a novel regimen to improve compliance.
The Journal of dermatological treatment 2001;12(2):75-9.
2001: van de Kerkhof P C
Therapeutic strategies: rotational therapy and combinations.
Clinical and experimental dermatology 2001;26(4):356-61.
2001: van De Kerkhof P C
New developments in the treatment of psoriasis.
Skin pharmacology and applied skin physiology 2001;14(3):129-35.
2001: Prins M; Swinkels O Q; Van de Kerkhof P C; Van der Valk P G
The impact of the frequency of short contact dithranol treatment.
European journal of dermatology : EJD 2001;11(3):214-8.
2001: Gerritsen M J; Van De Kerkhof P C; Langner A
Long-term safety of topical calcitriol 3 microg g(-1) ointment.
The British journal of dermatology 2001;144 Suppl 58():17-9.
2001: Seyger M M; van den Hoogen F H; van Vlijmen-Willems I M; van de Kerkhof P C; de Jong E M
Localized and systemic scleroderma show different histological responses to methotrexate therapy.
The Journal of pathology 2001;193(4):511-6.
2001: van de Kerkhof P C; Franssen M E
Psoriasis of the scalp. Diagnosis and management.
American journal of clinical dermatology 2001;2(3):159-65.
2001: van Rossum M M; van Erp P E; van de Kerkhof P C
Treatment of psoriasis with a new combination of calcipotriol and betamethasone dipropionate: a flow cytometric study.
Dermatology (Basel, Switzerland) 2001;203(2):148-52.
2001: van der Vleuten C J; van de Kerkhof P C
Management of scalp psoriasis: guidelines for corticosteroid use in combination treatment.
Drugs 2001;61(11):1593-8.
2000: van de Kerkhof P C
[Certification of curricula for graduate education of the specialist. Netherlands system of graduate education]
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2000;51(11):894-5.
2000: Prins M; Swinkels O Q; Bouwhuis S; de Gast M J; Bouwman-Boer Y; van der Valk P G; van de Kerkhof P C
Dithranol in a cream preparation: disperse or dissolve?
Skin pharmacology and applied skin physiology 2000;13(5):273-9.
2000: Seegers B A; Glade C P; van Hooijdonk C A; van Erp P E; de Jongh G J; van de Kerkhof P C
Flow-cytometric characterization of normal versus psoriatic epidermis using improved cell separation methodology.
Experimental dermatology 2000;9(4):266-70.
2000: Van Rossum M M; Mommers J M; Van Erp P E; Leyninger E; Clucas A; Van de Kerkhof P C
CD 2394, a novel synthetic retinoid, initiates an embryonic type of differentiation in hyperproliferative skin.
Acta dermato-venereologica 2000;80(2):98-101.
2000: Seegers B A; Andriessen M P; van Hooijdonk C A; de Bakker E S; van Vlijmen-Willems I M; Parker G L; van Erp P E; van de Kerkhof P C
Pharmacological effects of a specific leukotriene B(4) receptor antagonist (VML 295) on blood leukocytes, cutaneous inflammation and epidermal proliferation.
Skin pharmacology and applied skin physiology 2000;13(2):75-85.
2000: Mommers J M; Van Rossum M M; Kooijmans-Otero M E; Parker G L; van de Kerkhof P C
VML 295 (LY-293111), a novel LTB4 antagonist, is not effective in the prevention of relapse in psoriasis.
The British journal of dermatology 2000;142(2):259-66.
2000: Mommers J M; Goossen J W; van De Kerkhof P C; van Erp P E
Novel functional multiparameter flow cytometric assay to characterize proliferation in skin.
Cytometry 2000;42(1):43-9.
2000: Kuijpers A L; van de Kerkhof P C
Risk-benefit assessment of methotrexate in the treatment of severe psoriasis.
American journal of clinical dermatology 2000;1(1):27-39.
2000: Smit J V; de Jong E M; de Jongh G J; van de Kerkhof P C
Topical all-trans retinoic acid does not influence minimal erythema doses for UVB light in normal skin.
Acta dermato-venereologica 2000;80(1):66-7.
2000: van Rossum M M; Mommers J M; van de Kerkhof P C; van Erp P E
Coexpression of keratins 13 and 16 in human keratinocytes indicates association between hyperproliferation-associated and retinoid-induced differentiation.
Archives of dermatological research 2000;292(1):16-20.
2000: Castelijns F A; Gerritsen M J; van Erp P E; van de Kerkhof P C
Cell-kinetic evidence for increased recruitment of cycling epidermal cells in psoriasis: the ratio of histone and Ki-67 antigen expression is constant.
Dermatology (Basel, Switzerland) 2000;201(2):105-10.
2000: Mommers J M; van Rossum M M; van Erp P E; van De Kerkhof P C
Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis.
Dermatology (Basel, Switzerland) 2000;201(1):15-20.
2000: van de Kerkhof P C; de Hoop D; de Korte J; Cobelens S A; Kuipers M V
Patient compliance and disease management in the treatment of psoriasis in the Netherlands.
Dermatology (Basel, Switzerland) 2000;200(4):292-8.
2000: Castelijns F A; Gerritsen M J; van Erp P E; van de Kerkhof P C
Efficacy of calcipotriol ointment applied under hydrocolloid occlusion in psoriasis.
Dermatology (Basel, Switzerland) 2000;200(1):25-30.
1999: Alkemade J A; van Tongeren J H; van Haelst U J; Smals A; Steijlen P M; van de Kerkhof P C
Delayed diagnosis of glucagonoma syndrome.
Clinical and experimental dermatology 1999;24(6):455-7.
1999: van Rossum M M; Mommers J M; van Hooijdonk C A; van Erp P E; van de Kerkhof P C
The response of distant uninvolved psoriatic skin to standardised injury is not different from that in normal skin.
Skin pharmacology and applied skin physiology 1999;12(5):271-5.
1999: van der Vleuten C J; van Vlijmen-Willems I M; de Jong E M; van de Kerkhof P C
Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study on remission and relapse.
Archives of dermatological research 1999;291(7-8):390-5.
1999: Mommers J M; ter Meulen A C; van Erp P E; van de Kerkhof P C
Influence of tacalcitol on cell cycle kinetics of human keratinocytes following standardized injury.
Skin pharmacology and applied skin physiology 1999;12(4):174-81.
1999: Castelijns F A; Gerritsen M J; van Vlijmen-Willems I M; van Erp P E; van de Kerkhof P C
The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis.
Journal of the American Academy of Dermatology 1999;40(6 Pt 1):901-9.
1999: Castelijns F A; Gerritsen M J; van Vlijmen-Willems I M; van Erp P J; van de Kerkhof P C
Proliferation is the main epidermal target in the treatment of psoriatic plaques with once daily application of tacalcitol ointment.
Acta dermato-venereologica 1999;79(2):111-4.
1999: Mommers J M; van Rossum M M; van Hooijdonk C A; van Erp P E; van de Kerkhof P C
Quantification of epidermal cell populations in the centre and margin of stable psoriatic plaques.
Archives of dermatological research 1999;291(2-3):88-92.
1999: Castelijns F A; Gerritsen M J; van Erp P E; van de Kerkhof P C
Immunohistochemical assessment of keratin 16 on paraffin-embedded sections of normal and hyperproliferative skin: monoclonal antibodies Ks8.12 and LL025 in a comparative study.
Archives of dermatological research 1999;291(1):59-63.
1999: Mommers J M; van Erp P E; van De Kerkhof P C
Clobetasol under hydrocolloid occlusion in psoriasis results in a complete block of proliferation and in a rebound of lesions following discontinuation.
Dermatology (Basel, Switzerland) 1999;199(4):323-7.
1999: de Jong E M; Menke H E; van Praag M C; van De Kerkhof P C
Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study.
Dermatology (Basel, Switzerland) 1999;199(4):313-8.
1998: Castelijns F A; Ezendam J; Latijnhouwers M A; Van Vlijmen-Willems I M; Zeeuwin P L; Gerritsen M J; Van de Kerkhof P C; Van Erp P E
Epidermal cell kinetics by combining in situ hybridization and immunohistochemistry.
The Histochemical journal 1998;30(12):869-77.
1998: Andriessen M P; Niessen F B; Van de Kerkhof P C; Schalkwijk J
Hypertrophic scarring is associated with epidermal abnormalities: an immunohistochemical study.
The Journal of pathology 1998;186(2):192-200.
1998: Kuijpers A L; Van Pelt J P; Bergers M; Boegheim P J; Den Bakker J E; Siegenthaler G; Van de Kerkhof P C; Schalkwijk J
The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin.
The British journal of dermatology 1998;139(3):380-9.
1998: Latijnhouwers M A; Bergers M; Kuijpers A L; van der Vleuten C J; Dijkman H; van de Kerkhof P C; Schalkwijk J
Tenascin-C is not a useful marker for disease activity in psoriasis.
Acta dermato-venereologica 1998;78(5):331-4.
1998: Mommers J M; Castelijns F A; Seegers B A; Van Rossum M M; Van Hooijdonk C A; Van Erp P E; Van De Kerkhof P C
The effect of long-term treatment with tacalcitol on the psoriatic epidermis. A flow cytometric analysis.
The British journal of dermatology 1998;139(3):468-71.
1998: Van Pelt J P; De Jong E M; Seijger M M; Van Hooijdonk C A; De Bakker E S; Van Vlijmen I M; Parker G L; Van Erp P E; Van De Kerkhof P C
Investigation on a novel and specific leukotriene B4 receptor antagonist in the treatment of stable plaque psoriasis.
The British journal of dermatology 1998;139(3):396-402.
1998: van de Kerkhof P C
Follicular cysts and hyperkeratoses in early mycosis fungoides.
International journal of dermatology 1998;37(9):696-8.
1998: Seyger M M; van de Kerkhof P C; van Vlijmen-Willems I M; de Bakker E S; Zwiers F; de Jong E M
The efficacy of a new topical treatment for psoriasis: Mirak.
Journal of the European Academy of Dermatology and Venereology : JEADV 1998;11(1):13-8.
1998: Kuijpers A L; Pfundt R; Zeeuwen P L; Molhuizen H O; Mariman E C; van de Kerkhof P C; Schalkwijk J
SKALP/elafin gene polymorphisms are not associated with pustular forms of psoriasis.
Clinical genetics 1998;54(1):96-101.
1998: Gerritsen M J; Boezeman J B; Elbers M E; van de Kerkhof P C
Dithranol embedded in crystalline monoglycerides combined with phototherapy (UVB): a new approach in the treatment of psoriasis.
Skin pharmacology and applied skin physiology 1998;11(3):133-9.
1998: Glade C P; van Erp P E; Werner-Schlenzka H; van de Kerkhof P C
A clinical and flow cytometric model to study remission and relapse in psoriasis.
Acta dermato-venereologica 1998;78(3):180-5.
1998: Gerritsen M J; de Jong E M; van de Kerkhof P C
Linear lichen planopilaris of the face.
Journal of the American Academy of Dermatology 1998;38(4):633-5.
1998: van Pelt J P; de Jong E M; de Bakker E S; van de Kerkhof P C
Effects of systemic treatment with liarozole on cutaneous inflammation, epidermal proliferation and differentiation in extensive plaque psoriasis.
Skin pharmacology and applied skin physiology 1998;11(2):70-9.
1998: Le T K; Schalkwijk J; van de Kerkhof P C; van Haelst U; van der Valk P G
A histological and immunohistochemical study on chronic irritant contact dermatitis.
American journal of contact dermatitis : official journal of the American Contact Dermatitis Society 1998;9(1):23-8.
1998: van de Kerkhof P C; de Rooij M; Steijlen P M
Spontaneous course of hemangiomas: facts and speculations.
International journal of dermatology 1998;37(2):101-2.
1998: Glade C P; Van Der Vleuten C J; van Erp P E; De Jong E M; van de Kerkhof P C
The epidermis of chronic idiopathic lichen planus during topical treatment with the vitamin D3 analogue KH 1060.
Clinical and experimental dermatology 1998;23(1):14-8.
1998: van de Kerkhof P C
An update on vitamin D3 analogues in the treatment of psoriasis.
Skin pharmacology and applied skin physiology 1998;11(1):2-10.
1998: van de Kerkhof P C
The management of psoriasis.
The Netherlands journal of medicine 1998;52(1):40-5.
1998: van de Kerkhof P C; Cambazard F; Hutchinson P E; Haneke E; Wong E; Souteyrand P; Damstra R J; Combemale P; Neumann M H; Chalmers R J; Olsen L; Revuz J
The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis.
The British journal of dermatology 1998;138(1):84-9.
1998: van de Kerkhof P C; Rulo H F; van Pelt J P; van Vlijmen-Willems I M; De Jong E M
Expression of endoglin in the transition between psoriatic uninvolved and involved skin.
Acta dermato-venereologica 1998;78(1):19-21.
1998: van Pelt J P; Kuijpers S H; van de Kerkhof P C; de Jong E M
The CD11b/CD18-integrin in the pathogenesis of psoriasis.
Journal of dermatological science 1998;16(2):135-43.
1998: van Rossum M M; Mommers J M; van de Kerkhof P C; de Jongh G J; van Hooijdonk C A; van Erp P E
Multi parameter flow cytometric assessment of regenerative epidermis with special reference to the antiproliferative effect of occlusion.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1998;17(3):157-65.
1998: van de Kerkhof P C; de Hoop D; de Korte J; Kuipers M V
Scalp psoriasis, clinical presentations and therapeutic management.
Dermatology (Basel, Switzerland) 1998;197(4):326-34.
1998: van de Kerkhof P C; Steegers-Theunissen R P; Kuipers M V
Evaluation of topical drug treatment in psoriasis.
Dermatology (Basel, Switzerland) 1998;197(1):31-6.
1997: Andriessen M P; van den Born J; Latijnhouwers M A; Bergers M; van de Kerkhof P C; Schalkwijk J
Basal membrane heparan sulphate proteoglycan expression during wound healing in human skin.
The Journal of pathology 1997;183(3):264-71.
1997: Glade C P; van Erp P E; Boezeman J B; van de Kerkhof P C
Multiparameter flow cytometry as a tool to evaluate antipsoriatic therapy.
The British journal of dermatology 1997;137(3):367-75.
1997: van de Kerkhof P C
Combinations and comparisons.
Clinics in dermatology 1997;15(5):831-4.
1997: Kuijpers A L; Schalkwijk J; Rulo H F; Peperkamp J J; van de Kerkhof P C; de Jong E M
Extremely low levels of epidermal skin-derived antileucoproteinase/elafin in a patient with impetigo herpetiformis.
The British journal of dermatology 1997;137(1):123-9.
1997: van Pelt J P; de Jong E M; van Erp P E; Mitchell M I; Marder P; Spaethe S M; van Hooijdonk C A; Kuijpers A L; van de Kerkhof P C
The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111).
Biochemical pharmacology 1997;53(7):1005-12.
1997: Gerritsen M J; Elbers M E; de Jong E M; van de Kerkhof P C
Recruitment of cycling epidermal cells and expression of filaggrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skin.
Journal of dermatological science 1997;14(3):179-88.
1997: Seyger M M; van den Born J; Schalkwijk J; van de Kerkhof P C; de Jong E M
Altered distribution of heparan sulfate proteoglycans in psoriasis.
Acta dermato-venereologica 1997;77(2):105-9.
1997: van de Kerkhof P C; de Rooij M J
Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance.
The British journal of dermatology 1997;136(2):275-8.
1997: Kuijpers A L; Bergers M; Siegenthaler G; Zeeuwen P L; van de Kerkhof P C; Schalkwijk J
Skin-derived antileukoproteinase (SKALP) and epidermal fatty acid-binding protein (E-FABP): two novel markers of the psoriatic phenotype that respond differentially to topical steroid.
Acta dermato-venereologica 1997;77(1):14-9.
1997: Lucker G P; Heremans A M; Boegheim P J; van de Kerkhof P C; Steijlen P M
Oral treatment of ichthyosis by the cytochrome P-450 inhibitor liarozole.
The British journal of dermatology 1997;136(1):71-5.
1996: van der Vleuten C J; de Jong E M; van de Kerkhof P C
Epidermal differentiation characteristics of the psoriatic plaque during short contact treatment with dithranol cream.
Clinical and experimental dermatology 1996;21(6):409-14.
1996: Van de Kerkhof P C; Werfel T; Haustein U F; Luger T; Czarnetzki B M; Niemann R; Plänitz-Stenzel V
Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety.
The British journal of dermatology 1996;135(5):758-65.
1996: Feind-Koopmans A G; Lucker G P; van de Kerkhof P C
Acquired ichthyosiform erythroderma and sarcoidosis.
Journal of the American Academy of Dermatology 1996;35(5 Pt 2):826-8.
1996: Le M; Schalkwijk J; Siegenthaler G; van de Kerkhof P C; Veerkamp J H; van der Valk P G
Changes in keratinocyte differentiation following mild irritation by sodium dodecyl sulphate.
Archives of dermatological research 1996;288(11):684-90.
1996: Kuijpers A L; Zeeuwen P L; de Jongh G J; van de Kerkhof P C; Alkemade H A; Schalkwijk J
Skin-derived antileukoproteinase (SKALP) is decreased in pustular forms of psoriasis. A clue to the pathogenesis of pustule formation?
Archives of dermatological research 1996;288(11):641-7.
1996: Van de Kerkhof P C; Gerritsen M J; de Jong E M
Transition from symptomless to lesional psoriatic skin.
Clinical and experimental dermatology 1996;21(5):325-9.
1996: Glade C P; Van Erp P E; Van De Kerkhof P C
Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
The British journal of dermatology 1996;135(3):379-84.
1996: Van der Vleuten C J; Gerritsen M J; De Jong E M; Elbers M; De Jongh G J; van de Kerkhof P C
A novel dithranol formulation (Micanol): the effects of monotherapy and UVB combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in psoriasis vulgaris.
Acta dermato-venereologica 1996;76(5):387-91.
1996: van der Vleuten C J; Kroot E J; de Jong E M; van de Kerkhof P C
The immunohistochemical effects of a single challenge with an intermediate dose of ultraviolet B on normal human skin.
Archives of dermatological research 1996;288(9):510-6.
1996: Feind-Koopmans A; Van der Valk P G; Steijlen P M; Van de Kerkhof P C
Toxic pustuloderma associated with clemastine therapy.
Clinical and experimental dermatology 1996;21(4):293-5.
1996: van Bergen B H; Andriessen M P; Spruijt K I; van de Kerkhof P C; Schalkwijk J
Expression of SKALP/elafin during wound healing in human skin.
Archives of dermatological research 1996;288(8):458-62.
1996: van der Vleuten C J; de Jong E M; van de Kerkhof P C
Epidermal differentiation characteristics of the psoriatic plaque during treatment with calcipotriol.
Archives of dermatological research 1996;288(7):366-72.
1996: van de Kerkhof P C
Reduction of epidermal abnormalities and inflammatory changes in psoriatic plaques during treatment with vitamin D3 analogs.
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 1996;1(1):78-81.
1996: Glade C P; Seegers B A; Meulen E F; van Hooijdonk C A; van Erp P E; van de Kerkhof P C
Multiparameter flow cytometric characterization of epidermal cell suspensions prepared from normal and hyperproliferative human skin using an optimized thermolysin-trypsin protocol.
Archives of dermatological research 1996;288(4):203-10.
1996: Lucker G P; Steijen P M; Suykerbuyk E J; Kragballe K; Brandrup F; van de Kerkhof P C
Flow-cytometric investigation of epidermal cell characteristics in monogenic disorders of keratinization and their modulation by topical calcipotriol treatment.
Acta dermato-venereologica 1996;76(2):97-101.
1996: De Jong E M; Van De Kerkhof P C
Coexistence of palmoplantar lichen planus and lupus erythematosus with response to treatment using acitretin.
The British journal of dermatology 1996;134(3):538-41.
1996: vanDooren-Greebe R J; Kuijpers A L; Buijs W C; Kniest P H; Corstens F H; Nagengast F M; de Boo T; Willems J L; Duller P; van de Kerkhof P C
The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
The British journal of dermatology 1996;134(3):481-7.
1996: Van Dooren-Greebe R J; Lemmens J A; De Boo T; Hangx N M; Kuijpers A L; Van de Kerkhof P C
Prolonged treatment with oral retinoids in adults: no influence on the frequency and severity of spinal abnormalities.
The British journal of dermatology 1996;134(1):71-6.
1996: van der Vleuten C J; Gerritsen M J; Steijlen P M; de Jong E M; van de Kerkhof P C
A therapeutic approach to erythrodermic psoriasis: report of a case and a discussion of therapeutic options.
Acta dermato-venereologica 1996;76(1):65-7.
1996: Gerritsen M J; van Pelt J P; van de Kerkhof P C
Response of the clinically uninvolved skin of psoriatic patients to tape stripping during acitretin treatment.
Acta dermato-venereologica 1996;76(1):6-9.
1996: van der Vleuten C J; Snijders C G; de Jong E M; van de Kerkhof P C
Effects of calcipotriol and clobetasol-17-propionate on UVB-irradiated human skin: an immunohistochemical study.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1996;9(6):355-65.
1996: Van de Kerkhof P C; Van Erp P E
The role of epidermal proliferation in the pathogenesis of psoriasis.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1996;9(6):343-54.
1996: de Jong E M; Seegers B A; Gulinck M K; Boezeman J B; van de Kerkhof P C
Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients.
Dermatology (Basel, Switzerland) 1996;193(4):300-3.
1996: van de Kerkhof P C; van Pelt H; Lucker G P; Steijlen P M; Heremans A
Topical R-85355, a potent and selective 5-lipoxygenase inhibitor, fails to improve psoriasis.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1996;9(5):307-11.
1996: van der Valk P G; Snater E; Verbeek-Gijsbers W; Duller P; van de Kerkhof P C
Out-patient treatment of atopic dermatitis with crude coal tar.
Dermatology (Basel, Switzerland) 1996;193(1):41-4.
1996: Kuijpers A L; van Dooren-Greebe R J; van de Kerkhof P C
Acrodermatitis continua of Hallopeau: response to combined treatment with acitretin and calcipotriol ointment.
Dermatology (Basel, Switzerland) 1996;192(4):357-9.
1995: Andriessen M P; van Bergen B H; Spruijt K I; Go I H; Schalkwijk J; van de Kerkhof P C
Epidermal proliferation is not impaired in chronic venous ulcers.
Acta dermato-venereologica 1995;75(6):459-62.
1995: Glade C P; Botermans R J; van Erp P E; van de Kerkhof P C
The dynamics of the response of normal skin to single and multiple epicutaneous leukotriene B4 applications analysed by three-colour flow cytometry.
Acta dermato-venereologica 1995;75(6):437-41.
1995: van Dooren-Greebe R J; Kuijpers A L; Termorshuizen F; van de Kerkhof P C
Interruption of long-term methotrexate treatment in psoriasis. Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral methotrexate.
Acta dermato-venereologica 1995;75(5):393-6.
1995: Kuijpers A L; van Baar H M; van Gasselt M W; van de Kerkhof P C
The hair root pattern after calcipotriol treatment for scalp psoriasis.
Acta dermato-venereologica 1995;75(5):388-90.
1995: Glade C P; van Erp P E; van Hooijdonk C A; Elbers M E; van de Kerkhof P C
Topical treatment of psoriatic plaques with 1 alpha, 24 dihydroxyvitamin D3: a multiparameter flow cytometrical analysis of epidermal growth, differentiation and inflammation.
Acta dermato-venereologica 1995;75(5):381-5.
1995: Rulo H F; Westphal J R; van de Kerkhof P C; de Waal R M; van Vlijmen I M; Ruiter D J
Expression of endoglin in psoriatic involved and uninvolved skin.
Journal of dermatological science 1995;10(2):103-9.
1995: van Baar H M; van der Vleuten C J; van de Kerkhof P C
Dapsone versus topical immunotherapy in alopecia areata.
The British journal of dermatology 1995;133(2):270-4.
1995: Le T K; van der Valk P G; Schalkwijk J; van de Kerkhof P C
Changes in epidermal proliferation and differentiation in allergic and irritant contact dermatitis reactions.
The British journal of dermatology 1995;133(2):236-40.
1995: Snater E; Janssen E A; van der Valk P G; van de Kerkhof P C
Transepidermal water vapour loss is not increased during and following dithranol irritation.
The British journal of dermatology 1995;132(6):908-12.
1995: de Jong E M; Ferrier C M; de Zwart A; Wauben-Penris P J; Korstanje C; van de Kerkhof P C
Effects of topical treatment with budesonide on parameters for epidermal proliferation, keratinization and inflammation in psoriasis.
Journal of dermatological science 1995;9(3):185-94.
1995: van de Kerkhof P C
Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms.
The British journal of dermatology 1995;132(5):675-82.
1995: Kragballe K; Steijlen P M; Ibsen H H; van de Kerkhof P C; Esmann J; Sorensen L H; Axelsen M B
Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study.
Archives of dermatology 1995;131(5):556-60.
1995: Van de Kerkhof P C; Bos J D
Pathogenic aspects of psoriasis. Introduction.
Clinics in dermatology 1995;13(2):97-8.
1995: Van Ruissen F; Van de Kerkhof P C; Schalkwijk J
Signal transduction pathways in epidermal proliferation and cutaneous inflammation.
Clinics in dermatology 1995;13(2):161-90.
1995: Kuijpers A L; Alkemade H A; Schalkwijk J; van de Kerkhof P C
Topographic relation between skin-derived antileukoproteinase (SKALP) and leukocyte elastase in a case of annular pustular psoriasis.
Acta dermato-venereologica 1995;75(2):110-3.
1995: Alkemade H A; de Jongh G J; Arnold W P; van de Kerkhof P C; Schalkwijk J
Levels of skin-derived antileukoproteinase (SKALP)/elafin in serum correlate with disease activity during treatment of severe psoriasis with cyclosporin A.
The Journal of investigative dermatology 1995;104(2):189-93.
1995: van Dooren-Greebe R J; van de Kerkhof P C
Extensive extraspinal hyperostoses after long-term oral retinoid treatment in a patient with pityriasis rubra pilaris.
Journal of the American Academy of Dermatology 1995;32(2 Pt 2):322-5.
1995: van de Kerkhof P C; de Mare S; Arnold W P; van Erp P E
Epidermal regeneration and occlusion.
Acta dermato-venereologica 1995;75(1):6-8.
1995: van de Kerkhof P C; van Baar H M
Co-occurrence of plasma cell orificial mucositis and plasmoacanthoma. Report of a case and review of the literature.
Dermatology (Basel, Switzerland) 1995;191(1):53-5.
1995: van de Kerkhof P C; Steijlen P M
IgA deficiency and psoriasis: relevance of IgA in the pathogenesis of psoriasis.
Dermatology (Basel, Switzerland) 1995;191(1):46-8.
1995: van de Kerkhof P C; Goos M; Christophers E; Baudin M; Dupuy P
Inhibitor of the release of mast cell mediators does not improve the psoriatic plaque.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1995;8(1-2):25-9.
1995: Lucker G P; van de Kerkhof P C; Cruysberg J R; der Kinderen D J; Steijlen P M
Topical treatment of Sjögren-Larsson syndrome with calcipotriol.
Dermatology (Basel, Switzerland) 1995;190(4):292-4.
1994: Elbers M E; Gerritsen M J; van de Kerkhof P C
The effect of topical application of the platelet-activating factor-antagonist, Ro 24-0238, in psoriasis vulgaris--a clinical and immunohistochemical study.
Clinical and experimental dermatology 1994;19(6):453-7.
1994: Alkemade H A; van Vlijmen-Willems I M; van Haelst U J; van de Kerkhof P C; Schalkwijk J
Demonstration of skin-derived antileukoproteinase (SKALP) and its target enzyme human leukocyte elastase in squamous cell carcinoma.
The Journal of pathology 1994;174(2):121-9.
1994: Lucker G P; van de Kerkhof P C; van Dïjk M R; Steijlen P M
Effect of topical calcipotriol on congenital ichthyoses.
The British journal of dermatology 1994;131(4):546-50.
1994: Van de Kerkhof P C; Van Bergen B; Spruijt K; Kuiper J P
Age-related changes in wound healing.
Clinical and experimental dermatology 1994;19(5):369-74.
1994: Alkemade J A; Molhuizen H O; Ponec M; Kempenaar J A; Zeeuwen P L; de Jongh G J; van Vlijmen-Willems I M; van Erp P E; van de Kerkhof P C; Schalkwijk J
SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes.
Journal of cell science 1994;107 ( Pt 8)():2335-42.
1994: van Ruissen F; van Erp P E; de Jongh G J; Boezeman J B; van de Kerkhof P C; Schalkwijk J
Cell kinetic characterization of growth arrest in cultured human keratinocytes.
Journal of cell science 1994;107 ( Pt 8)():2219-28.
1994: Lucker G P; Van de Kerkhof P C; Steijlen P M
The hereditary palmoplantar keratoses: an updated review and classification.
The British journal of dermatology 1994;131(1):1-14.
1994: Gerritsen M J; Boezeman J B; van Vlijmen-Willems I M; Van de Kerkhof P C
The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study.
The British journal of dermatology 1994;131(1):57-63.
1994: Chang A; Lucker G P; van de Kerkhof P C; Steijlen P M
Pachyonychia congenita in the absence of other syndrome abnormalities.
Journal of the American Academy of Dermatology 1994;30(6):1017-8.
1994: Van de Kerkhof P C; Steijlen P M
Topical treatment of pityriasis rubra pilaris with calcipotriol.
The British journal of dermatology 1994;130(5):675-8.
1994: Lucker G P; van de Kerkhof P C; Steijlen P M
Topical calcipotriol in the treatment of epidermolytic palmoplantar keratoderma of Vörner.
The British journal of dermatology 1994;130(4):543-5.
1994: van de Kerkhof P C; Chang A; van der Walle H B; van Vlijmen-Willems I; Boezeman J B; Huigen-Tijdink R
Weekly treatment of psoriasis with a hydrocolloid dressing in combination with triamcinolone acetonide. A controlled comparative study.
Acta dermato-venereologica 1994;74(2):143-6.
1994: Steijlen P M; Van Dooren-Greebe R J; Van de Kerkhof P C
Acitretin in the treatment of lamellar ichthyosis.
The British journal of dermatology 1994;130(2):211-4.
1994: Van Dooren-Greebe R J; Kuijpers A L; Mulder J; De Boo T; Van de Kerkhof P C
Methotrexate revisited: effects of long-term treatment in psoriasis.
The British journal of dermatology 1994;130(2):204-10.
1994: Gerritsen M J; Rulo H F; Arnold W P; Van de Kerkhof P C
Response of the clinically uninvolved skin of psoriatic patients to repeated tape stripping during cyclosporin A treatment.
The British journal of dermatology 1994;130(2):181-8.
1994: van de Kerkhof P C
On the efficacy of dapsone in granuloma faciale.
Acta dermato-venereologica 1994;74(1):61-2.
1994: Van Baar H M; Van Vlijmen I M; Ramaekers F C; Van Muijen G N; Troyanovsky S M; Perret C M; Van de Kerkhof P C; Schalkwijk J
Cytokeratin expression in alopecia areata hair follicles.
Acta dermato-venereologica 1994;74(1):28-32.
1994: Gerritsen M J; van Erp P E; van Vlijmen-Willems I M; Lenders L T; van de Kerkhof P C
Repeated tape stripping of normal skin: a histological assessment and comparison with events seen in psoriasis.
Archives of dermatological research 1994;286(8):455-61.
1993: Arnold W P; Gerritsen M J; van de Kerkhof P C
Cyclosporin A does not affect epidermal proliferation following standardized injury.
The British journal of dermatology 1993;129(6):751-3.
1993: Arnold W P; Gerritsen M J; van de Kerkhof P C
Response of nail psoriasis to cyclosporin.
The British journal of dermatology 1993;129(6):750-1.
1993: van Hooijdonk C A; van Erp P E; Freund R L; de Jongh G J; Schalkwijk J; van de Kerkhof P C; Mier P D
Cell kinetic characterization of the epidermal growth factor dependent BALB/MK line using flow cytometric analysis of DNA content and iododeoxyuridine incorporation.
Cell proliferation 1993;26(6):567-76.
1993: Gerritsen M J; Rulo H F; Van Vlijmen-Willems I; Van Erp P E; van de Kerkhof P C
Topical treatment of psoriatic plaques with 1,25-dihydroxyvitamin D3: a cell biological study.
The British journal of dermatology 1993;128(6):666-73.
1993: Arnold W P; Pennings B J; van de Kerkhof P C
The induction of epidermal ornithine decarboxylase following UV-B irradiation is inhibited by estriol.
Acta dermato-venereologica 1993;73(2):92-3.
1993: Rulo H F; van Vlijmen-Willems I M; Schalkwijk J; Verstraeten A A; van de Kerkhof P C
Normal human skin demonstrates marked site-variation of tenascin expression, not correlated to epidermal proliferation (Ki-67 binding).
Journal of dermatological science 1993;5(1):54-7.
1993: van de Kerkhof P C; de Jong E M; Arnold W P; de Mare S; Hol C W
[Vitamin D 3 analogs, e new therapy for psoriasis]
Nederlands tijdschrift voor geneeskunde 1993;137(5):232-6.
1993: Mier P D; van Hooijdonk C A; Freund R F; de Jongh G J; van Erp P E; van de Kerkhof P C
EGF induces ornithine decarboxylase transcription in Balb/MK keratinocytes: a proposed mechanism for the TGF alpha autocrine loop.
Archives of dermatological research 1993;285(4):236-8.
1993: Arnold W P; Glade C P; Mier P D; van de Kerkhof P C
Effects of sphingosine, isoquinoline and tannic acid on the human tape-stripping model and the psoriatic lesion.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1993;6(3):193-9.
1993: van de Kerkhof P C
Spontaneous resolution of keratosis lichenoides chronica.
Dermatology (Basel, Switzerland) 1993;187(3):200-4.
1993: Steijlen P M; Reifenschweiler D O; Ramaekers F C; van Muijen G N; Happle R; Link M; Ruiter D J; van de Kerkhof P C
Topical treatment of ichthyoses and Darier's disease with 13-cis-retinoic acid. A clinical and immunohistochemical study.
Archives of dermatological research 1993;285(4):221-6.
1993: van Vlijmen-Willems I M; Chang A; Boezeman J B; van de Kerkhof P C
The immunohistochemical effect of a hydrocolloid occlusive dressing (DuoDERM E) in psoriasis vulgaris.
Dermatology (Basel, Switzerland) 1993;187(4):257-62.
1992: de Jong E M; van Erp P E; van Vlijmen I M; van de Kerkhof P C
The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene-B4--an immunohistochemical study.
Clinical and experimental dermatology 1992;17(6):413-20.
1992: van der Steen P H; van Baar H M; Boezeman J B; van Erp P E; van Vlijmen I M; van de Kerkhof P C
Epidermal proliferation and keratinization following standardized elicitation with diphenylcyclopropenone.
Clinical and experimental dermatology 1992;17(5):316-20.
1992: Arnold W P; Pennings B J; van de Kerkhof P C
The induction of ornithine decarboxylase in human epidermis is independent of lipoxygenase and cyclo-oxygenase pathways.
The Journal of dermatology 1992;19(8):461-4.
1992: van de Kerkhof P C; van Dooren-Greebe R J; Steijlen P M
Acitretin in the treatment of mal de Meleda.
The British journal of dermatology 1992;127(2):191-2.
1992: Alkemade H; van de Kerkhof P; Schalkwijk J
Demonstration of skin-derived antileukoproteinase (SKALP) in urine of psoriatic patients.
The Journal of investigative dermatology 1992;99(1):3-7.
1992: Bischoff R; De Jong E M; Rulo H F; Sendagorta E; Czarnetzki B M; Van de Kerkhof P C
Topical application of 13-cis-retinoic acid in the treatment of chronic plaque psoriasis.
Clinical and experimental dermatology 1992;17(1):9-12.
1992: de Zwart A J; de Jong E M; van de Kerkhof P C
Topical application of dithranol on normal skin induces epidermal hyperproliferation and increased Ks8.12 binding.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1992;5(1):34-40.
1992: van Baar H M; Perret C M; van Vlijmen I M; van de Kerkhof P C; Happle R; Schalkwijk J
Abnormal expression of Ki-67 antigen in hair follicle of alopecia areata.
Acta dermato-venereologica 1992;72(3):161-4.
1992: Schoorl W J; van Baar H J; van de Kerkhof P C
The hair root pattern in psoriasis of the scalp.
Acta dermato-venereologica 1992;72(2):141-2.
1991: Arnold W P; Lintsen A M; Van de Kerkhof P C; Mier P D
Cyclo-oxygenase products do not participate in the induction of ornithine decarboxylase in human epidermis.
The British journal of dermatology 1991;125(6):577-9.
1991: de Jong E M; van Erp P E; Ruiter D J; van de Kerkhof P C
Immunohistochemical detection of proliferation and differentiation in discoid lupus erythematosus.
Journal of the American Academy of Dermatology 1991;25(6 Pt 1):1032-8.
1991: Steijlen P M; van Dooren-Greebe R J; Happle R; Van de Kerkhof P C
Ichthyosis bullosa of Siemens responds well to low-dosage oral retinoids.
The British journal of dermatology 1991;125(5):469-71.
1991: van de Kerkhof P C
Common pathways for epidermal growth and inflammation and their relevance in the pathogenesis of psoriasis.
International journal of dermatology 1991;30(11):755-62.
1991: Arnold W P; van de Kerkhof P C
The induction of epidermal ornithine decarboxylase following tape stripping is inhibited by a topical vitamin D3 analogue (MC903).
The British journal of dermatology 1991;125(1):6-8.
1991: van der Steen P; van de Kerkhof P; der Kinderen D; van Vlijmen I; Happle R
Clinical and immunohistochemical responses of plantar warts to topical immunotherapy with diphenylcyclopropenone.
The Journal of dermatology 1991;18(6):330-3.
1991: Schlingemann R O; Rietveld F J; Kwaspen F; van de Kerkhof P C; de Waal R M; Ruiter D J
Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue.
The American journal of pathology 1991;138(6):1335-47.
1991: van de Kerkhof P C; Peereboom-Stegeman J H; Boeijen J
An ultrastructural study of the response of normal skin to epicutaneous application of leukotriene B4.
The Journal of dermatology 1991;18(5):271-6.
1991: Mali-Gerrits M G; Gaasbeek D; Boezeman J; van de Kerkhof P C
Psoriasis therapy and the risk of skin cancers.
Clinical and experimental dermatology 1991;16(2):85-9.
1991: de Jong E M; van de Kerkhof P C
Simultaneous assessment of inflammation and epidermal proliferation in psoriatic plaques during long-term treatment with the vitamin D3 analogue MC903: modulations and interrelations.
The British journal of dermatology 1991;124(3):221-9.
1991: Van de Kerkhof P C; Kuppens L H; Van Vlijmen Y; Schalkwijk J
Distribution of skin-derived antileucoproteases (SKALP) in the marginal zone of the spreading psoriatic lesion.
The British journal of dermatology 1991;124(1):10-2.
1991: Rulo H F; van de Kerkhof P C
Treatment of inflammatory linear verrucous epidermal nevus.
Dermatologica 1991;182(2):112-4.
1991: de Jong E M; van Vlijmen I M; van Erp P E; Ramaekers F C; Troyanovski S M; van de Kerkhof P C
Keratin 17: a useful marker in anti-psoriatic therapies.
Archives of dermatological research 1991;283(7):480-2.
1991: de Jong E M; van Vlijmen I M; Scholte J C; Buntinx A; Friedman B; Tanaka W; van de Kerkhof P C
Clinical and biochemical effects of an oral leukotriene biosynthesis inhibitor (MK886) in psoriasis.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1991;4(4):278-85.
1991: de Jong E; Rulo H F; van de Kerkhof P C
Inflammatory linear verrucous epidermal naevus (ILVEN) versus linear psoriasis. A clinical, histological and immunohistochemical study.
Acta dermato-venereologica 1991;71(4):343-6.
1991: Steijlen P M; Happle R; van Muijen G N; van de Kerkhof P C
Topical treatment with 13-cis-retinoic acid improves Darier's disease and induces the expression of a unique keratin pattern.
Dermatologica 1991;182(3):178-83.
1991: Wozel G; Chang A; Zultak M; Czarnetzki B M; Happle R; Barth J; van de Kerkhof P C
The effect of topical retinoids on the leukotriene-B4-induced migration of polymorphonuclear leukocytes into human skin.
Archives of dermatological research 1991;283(3):158-61.
1990: Arnold W P; van Hooijdonk C A; Mier P D; van de Kerkhof P C
Induction of ornithine decarboxylase following sellotape stripping in normal and psoriatic skin.
The British journal of dermatology 1990;123(5):581-5.
1990: van Dooren-Greebe R J; van de Kerkhof P C; Steijlen P M; Happle R
[Acitretin therapy in keratinization disorders]
Nederlands tijdschrift voor geneeskunde 1990;134(41):1995-2000.
1990: van de Kerkhof P C; Weemaes C M
Skin manifestations in congenital deficiency of leucocyte-adherence glycoproteins (CDLG).
The British journal of dermatology 1990;123(3):395-401.
1990: de Mare S; de Jong E G; van de Kerkhof P C
DNA content and Ks8.12 binding of the psoriatic lesion during treatment with the vitamin D3 analogue MC903 and betamethasone.
The British journal of dermatology 1990;123(3):291-5.
1990: de Mare S; de Jong E; Van Erp P E; Van de Kerkhof P C
Markers for proliferation and keratinization in the margin of the active psoriatic lesion.
The British journal of dermatology 1990;122(4):469-75.
1990: Wozel G; Chang A; Barth J; Happle R; van de Kerkhof P C
Effect of leukotriene B5 on the accumulation of polymorphonuclear leukocytes in unstimulated and leukotriene B4-stimulated human skin.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1990;3(1):45-8.
1990: van de Kerkhof P C; Steijlen P M; van Dooren-Greebe R J; Happle R
Acitretin in the treatment of erythrokeratodermia variabilis.
Dermatologica 1990;181(4):330-3.
1990: van de Kerkhof P C; Timmerman M G
The effect of clobetasol-17-propionate and crude coal tar on dithranol-induced inflammation. A clinical and biochemical study.
Acta dermato-venereologica 1990;70(5):434-7.
1990: Chang A; Schalkwijk J; Happle R; van de Kerkhof P C
Elastase-inhibiting activity in scaling skin disorders.
Acta dermato-venereologica 1990;70(2):147-51.
1990: Timmerman M G; Mier P D; van de Kerkhof P C
Studies on the time course of dithranol-induced inflammation by quantification of alkaline phosphatase.
Acta dermato-venereologica 1990;70(1):66-9.
1990: Bergers M; van de Kerkhof P C; Happle R; Mier P D
Membrane-bound phospholipase C activity in normal and psoriatic epidermis.
Acta dermato-venereologica 1990;70(1):57-9.
1990: Chang A; Steegmans P; van de Kerkhof P C
Tetracycline does not affect the trauma- and leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes.
Acta dermato-venereologica 1990;70(1):46-8.
1990: Paulissen M; Peereboom-Stegeman J H; van de Kerkhof P C
An ultrastructural study of transcutaneous migration of polymorphonuclear leukocytes following application of leukotriene B4.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1990;3(4):236-47.
1990: de Mare S; van Erp P E; Ramaekers F C; van de Kerkhof P C
Flow cytometric quantification of human epidermal cells expressing keratin 16 in vivo after standardized trauma.
Archives of dermatological research 1990;282(2):126-30.
1989: van Erp P E; Rijzewijk J J; Boezeman J B; Leenders J; de Mare S; Schalkwijk J; van de Kerkhof P C; Ramaekers F C; Bauer F W
Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments.
The American journal of pathology 1989;135(5):865-70.
1989: van Dooren-Greebe R J; van de Kerkhof P C; Happle R
Acitretin monotherapy in Darier's disease.
The British journal of dermatology 1989;121(3):375-9.
1989: Van Erp P E; De Mare S; Rijzewijk J J; Van de Kerkhof P C; Bauer F W
A sequential double immunoenzymic staining procedure to obtain cell kinetic information in normal and hyperproliferative epidermis.
The Histochemical journal 1989;21(6):343-7.
1989: Chang A; Alkemade H; van de Kerkhof P C
Dithranol modulates the leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes.
The Journal of investigative dermatology 1989;92(6):806-8.
1989: van de Kerkhof P C; van Bokhoven M; Zultak M; Czarnetzki B M
A double-blind study of topical 1 alpha,25-dihydroxyvitamin D3 in psoriasis.
The British journal of dermatology 1989;120(5):661-4.
1989: de Mare S; Van Erp P E; van de Kerkhof P C
Epidermal hyperproliferation assessed by the monoclonal antibody Ks8.12 on frozen sections.
The Journal of investigative dermatology 1989;92(1):130-1.
1989: Beurskens T; Chang A; van Erp P E; van de Kerkhof P C
Epidermal proliferation and accumulation of polymorphonuclear leukocytes in the psoriatic lesion.
Dermatologica 1989;178(2):67-72.
1989: van de Kerkhof P C; Chang A
Migration of polymorphonuclear leukocytes in psoriasis.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1989;2(3):138-54.
1989: de Mare S; Calis N; den Hartog G; van de Kerkhof P C
Outpatient treatment with short-contact dithranol. The impact of frequent concentration adjustments.
Acta dermato-venereologica 1989;69(5):449-51.
1989: van Dooren-Greebe R J; van de Kerkhof P C; Chang A; Happle R
Acitretin monotherapy in acrodermatitis continua Hallopeau.
Acta dermato-venereologica 1989;69(4):344-6.
1989: van de Kerkhof P C; Fokkink H J
Irritancy of dithranol in normally pigmented and depigmented skin of patients with vitiligo.
Acta dermato-venereologica 1989;69(3):236-8.
1989: de Mare S; van de Kerkhof P C; Happle R
Dithranol in the treatment of inflammatory linear verrucous epidermal nevus.
Acta dermato-venereologica 1989;69(1):77-80.
1988: van Bokhoven M G; de Mare S; Czarnetzki B M; van Erp P E; Boezeman J B; van de Kerkhof P C
Active vitamin D3 does not suppress recruitment of G0 cells following injury.
The British journal of dermatology 1988;119(6):737-42.
1988: van de Kerkhof P C; de Vaan G A; Holland R
Pyoderma gangrenosum in acute myeloid leukaemia during immunosuppression.
European journal of pediatrics 1988;148(1):34-6.
1988: Chang A; Alkemade J A; van de Kerkhof P C
PUVA and UVB inhibit the intra-epidermal accumulation of polymorphonuclear leukocytes.
The British journal of dermatology 1988;119(3):281-7.
1988: Bergers M; Verhagen D R; Jongerius M; van de Kerkhof P C; Mier P D
A unique phospholipase A2 in human epidermis: its physiologic function and its level in certain dermatoses.
The Journal of investigative dermatology 1988;90(1):23-5.
1988: van de Kerkhof P C; Lammers A M
Intraepidermal accumulation of polymorphonuclear leukocytes in annular pustular psoriasis.
Dermatologica 1988;176(6):282-7.
1988: de Mare S; Calis N; den Hartog G; van Erp P E; van de Kerkhof P C
The relevance of salicylic acid in the treatment of plaque psoriasis with dithranol creams.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1988;1(4):259-64.
1988: van de Kerkhof P C; Chang A; van Dooren-Greebe R; Geiger J M; Happle R
Intra-epidermal accumulation of polymorphonuclear leukocytes in persistent palmoplantar pustulosis during treatment with acitretin.
Acta dermato-venereologica 1988;68(6):499-503.
1988: Chang A; van de Kerkhof P C
Topical application of clobetasol-17-propionate inhibits the intra-epidermal accumulation of polymorphonuclear leukocytes.
Acta dermato-venereologica 1988;68(1):57-60.
1987: van de Kerkhof P C; den Arend J A; Bousema M T; Stolz E
Localized unilateral hyperhidrosis.
The British journal of dermatology 1987;117(6):779-82.
1987: Lammers A M; van de Kerkhof P C
Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions.
The British journal of dermatology 1987;117(5):541-4.
1987: Lammers A M; van de Kerkhof P C
Etretinate modulates the leukotriene B4 induced intra-epidermal accumulation of polymorphonuclear leukocytes.
The British journal of dermatology 1987;117(3):297-300.
1987: Lammers A M; van de Kerkhof P C; Mier P D
Reduction of leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes by methotrexate in psoriasis.
The British journal of dermatology 1987;116(5):667-71.
1987: van Baar H M; van de Kerkhof P C; Schalkwijk J; Mier P D
Cutaneous superoxide dismutase activity in psoriasis.
The British journal of dermatology 1987;116(3):462-3.
1987: Happle R; van de Kerkhof P C; Traupe H
Retinoids in disorders of keratinization: their use in adults.
Dermatologica 1987;175 Suppl 1():107-24.
1987: van de Kerkhof P C; Lammers A M; Mier P D; Happle R
Leukotriene B4-induced accumulation of polymorphonuclear leukocytes in psoriatic skin.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17B():637-9.
1987: Dijkstra A C; Vermeesch-Markslag A M; Vromans E W; Happle R; van de Kerkhof P C; Zwanenburg B; Vos F; Vermorken A J
Substrate specific sulfatase activity from hair follicles in recessive X-linked ichthyosis.
Acta dermato-venereologica 1987;67(5):369-76.
1986: Lammers A M; van de Kerkhof P C; Schalwijk J; Mier P D
Elastase, a marker for neutrophils in skin infiltrates.
The British journal of dermatology 1986;115(2):181-6.
1986: Bauer F W; de Grood R M; van de Kerkhof P C
Hyperdiploid cells in skin infiltrates.
The British journal of dermatology 1986;114(1):136-8.
1984: van de Kerkhof P C; Fleuren E; van Rennes H; Mier P D
Metabolic changes in the psoriatic lesion during therapy.
The British journal of dermatology 1984;110(4):411-5.
1983: van de Kerkhof P C; van Rennes H; de Grood R M; de Jongh G J; Bauer F W; Mier P D
Response of the clinically uninvolved skin of psoriatic patients to standardized injury.
The British journal of dermatology 1983;109(3):287-94.
1983: van de Kerkhof P C; van Rennes H; de Grood R; Bauer F W; Mier P D
Metabolic changes at the margin of the spreading psoriatic lesion.
The British journal of dermatology 1983;108(6):647-52.
1983: van de Kerkhof P C; van Rennes H; Mier P D
Quantification of alkaline phosphatase in lesions and uninvolved skin of psoriatic patients.
Acta dermato-venereologica 1983;63(3):231-2.

Sign-in to see more